Lessons Learned is STAT Plus’ weekly column on careers in biomedicine. If you’re thinking of jumping from academics to industry/business or vice versa, join us each week for useful tips. And if you’ve recently jumped, send me a note: [email protected] Your experience might make a future column.
Who we talked to:
Omid Veiseh, 39. Assistant professor of bioengineering at Rice University. Co-founder, Sigilon Therapeutics. Foe of micromanaging.
